GCG and Hyperglycemia: In apparent conflict with those findings, administration of the glucagon‐like peptide‐1 (GLP‐1) agonist (and inhibitor of glucagon secretion) liraglutide to STZ‐diabetic rats normalized the increase in plasma glucagon without significantly affecting the hyperglycemia (Meek et al., 2015).